Cerevel Therapeutics Holdings, Inc.
CERENASDAQ
USReal-Time Price
USReal-Time Price$44.96USD
+0.33 (+0.74%)Today
BTI Score
Near Future
43
Long Term
38
BTI Fair Market Cap
Needs validation
Biotechnology
High Risk
Cerevel Therapeutics Holdings, Inc. (CERE) Key Statistics
All Cerevel Therapeutics Holdings, Inc. (CERE) key statistics in one place: market cap, valuation multiples, profitability, growth and risk metrics.
Valuation Measures
Market Cap$8.19B
Enterprise Value$7.68B
Trailing P/E—
Forward P/E—
PEG Ratio—
Price / Sales (TTM)—
Price / Book—
EV / Revenue0.00
EV / EBITDA—
Financial Highlights
Fiscal Year End—
Most Recent Quarter—
Profit Margin—
Operating Margin—
Return on Assets—
Return on Equity—
Quarterly Rev. Growth—
Gross Profit—
EBITDA—
Net Income—
Diluted EPS$-4.70
Total Cash—
Total Debt—
Free Cash Flow—
Trading Information
Beta (5Y Monthly)1.18
52-Week Change—
S&P 500 52-Wk Change—
52-Week High$44.99
52-Week Low$19.59
50-Day MA—
200-Day MA—
Avg. Volume18.57M
Shares Outstanding875.2M
Float815.4M
Short % of Float—
Short Ratio—